Clinical Trial Update: A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ABT-378 (lopinavir) boosted with ritonavir in HIV-infected patients who previously received protease inhibitors; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir (lopinavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 1 | Status: COMPLETED